Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study

Yun-Bo He; Jiao Hu; Zhi Liu; Zi-Cheng Xiao; Jin-Hui Liu; Hai-Su Liang; Wen-Zhi Deng; Zhi-Wei Li; Jun Zhang; Jia-Quan Long; Ning Gao; Bin Huang; Xi Guo; Zhen-Yu Ou; Jin-Bo Chen; Pei-Hua Liu; Min-Feng Chen; Hui-Huang Li; Rui-Zhe Wang; Xiao Guan; Shi-Yu Tong; Yang-Le Li; Wei He; Yan-Hua Zhao; Zhi-Yong Cai; Yu Gan; Cheng Zhao; Yu Cui; Yuan-Qing Dai; Yi Cai; Zhen-Yu Nie; Wei-Min Zhou; Bo-Han Zhou; Ming-Hui Hu; Ben-Yi Fan; Ding-Shan Deng; Xiong-Bing Zu

doi:10.1016/j.mmr.2026.100001

Your Location：

Home >

Browse articles >

Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study

RESEARCH | Updated：2026-05-11

- Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study
- Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study
- 军事医学研究（英文） 2026年
- Affiliations：
  
  Department of Urology, Xiangya Hospital, Central South University, Changsha 410008, China
  National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410008, China
  Department of Urology, the Second Affiliated Hospital, Guizhou Medical University, Guiyang 550000, China
  Department of Pathology, the Third Xiangya Hospital of Central South University, Changsha 410013, China
  Department of Urology, the Second Hospital of University of South China, Hengyang 421001, Hunan, China
  Department of Imaging, the First People’s Hospital of Kaili, Kaili 556000, Guiyang, China
  Department of Imaging, the Second Affiliated Hospital, Guizhou Medical University, Kaili 556000, Guiyang, China
  Department of Urology, Xiangya Boai Rehabilitation Hospital, Changsha 410146, China
  Department of Urology, Hunan Provincial People’s Hospital/the First Affiliated Hospital of Hunan Normal University, Changsha 410005, China
- Author bio：
  
  Ben-Yi Fan, fanbenyi2009@yeah.net
  Ding-Shan Deng, dds15116217256@163.com;
  *Xiong-Bing Zu, zuxbxy@csu.edu.cn;
- Funds：
  
  the Noncommunicable Chronic Diseases-National Science and Technology Major Project(2024ZD0525700);the National Natural Science Foundation of China(81902592;82070785;82303760;82373337);the China Postdoctoral Innovation Talents Support Program(BX20230431);the China Postdoctoral Science Foundation(2023M733951);the Hunan Natural Science Foundation(2023JJ40946;2024JJ2093);the Hunan Provincial Key Area Research Plan(2023SK2016);the Hunan Province Young Talents Program(2023RC3073);the Changsha Natural Science Foundation(kq2208377);the Youth Science Foundation of Xiangya Hospital(2022Q20);the National Clinical Research Center for Geriatric Disorders(2022LNJJ04);the Central South University Research Programme of Advanced Interdisciplinary Studies(2023QYJC029);the Health Research Project of Hunan Provincial Health Commission(202204054669);the Scientific Research Program of FuRong Laboratory(2024PT5102)
- DOI：10.1016/j.mmr.2026.100001
  中图分类号：
- 收稿：2025-05-25，
  
  修回：2026-03-05，
  
  纸质出版：2026-03
- Accepted：
Scan QR Code
Yun-Bo He, Jiao Hu, Zhi Liu, 等. Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study[J/OL]. 军事医学研究（英文）, 2026.

He YB, Hu J, Liu Z, Xiao ZC, Liu JH, Liang HS, et al. Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study. Mil Med Res. 2026;13(1):100001.
Yun-Bo He, Jiao Hu, Zhi Liu, 等. Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study[J/OL]. 军事医学研究（英文）, 2026. DOI： 10.1016/j.mmr.2026.100001.

He YB, Hu J, Liu Z, Xiao ZC, Liu JH, Liang HS, et al. Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study. Mil Med Res. 2026;13(1):100001. DOI： 10.1016/j.mmr.2026.100001.

摘要

Abstract

Background:

Bladder cancer (BLCA) is a prevalent malignancy characterized by high recurrence and poor prognosis

particularly muscle-invasive bladder cancer (MIBC). Histopathology

the gold standard for assessing muscle invasion

often suffers from sampling errors and operator dependency

underscoring the need for non-invasive

accurate preoperative assessment methods. This study aimed to develop and validate a hybrid artificial intelligence (AI) model based on computed tomography (CT) radiomics and deep learning (DL) to predict MIBC and overall survival (OS) preoperatively in BLCA patients.

Methods:

A total of 1370 patients from 6 academic medical centers were retrospectively included. Preoperative contrast-enhanced CT scans were analyzed to extract handcrafted radiomic features using PyRadiomics and DL features using ResNet101

followed by machine learning (ML)-based modeling for prediction. A hybrid model combining radiomic and DL features was constructed and validated in internal and external cohorts. Model performance was evaluated using metrics such as the area under the curve (AUC) and Cox proportional hazards analysis for OS prediction.

Results:

The DL radiomics nomogram (DLRN) model demonstrated superior diagnostic performance

achieving an AUC of 0.807 in the internal validation cohort and 0.783 in the external multi-center validation cohort for predicting muscle invasion. The DLRN generated an imaging-derived risk score (DLRN score)

which was subsequently incorporated as one covariate into a multivariable Cox proportional hazards model together with clinicopathological variables to evaluate OS. Using this approach

patients were effectively stratified into high- and low-risk groups for OS

showing robust generalizability across diverse clinical settings. AI-assisted diagnostics significantly improved the sensitivity and accuracy of urologists

particularly among less experienced clinicians.

Conclusion:

The DLRN model provides a reliable

non-invasive tool for preoperative assessment of muscle invasion and prognosis in BLCA. Addressing histopathology limitations

it offers valuable insights for personalized treatment strategies

paving the way for precision oncology in real-world clinical applications.

关键词

Keywords

references

Zi H , Liu MY , Luo LS , Huang Q , Luo PC , Luan HH , et al . Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021 . Mil Med Res . 2024 ; 11 ( 1 ): 64 .

Siegel RL , Miller KD , Wagle NS , Jemal A . Cancer statistics, 2023 . CA Cancer J Clin . 2023 ; 73 ( 1 ): 17 - 48 .

Mancini M , Righetto M , Zumerle S , Montopoli M , Zattoni F . The bladder EpiCheck test as a non-invasive tool based on the identification of DNA methylation in bladder cancer cells in the urine: a review of published evidence . Int J Mol Sci . 2020 ; 21 ( 18 ): 6542 .

Kamoun A , De Reyniès A , Allory Y , Sjödahl G , Robertson AG , Seiler R , et al . A consensus molecular classification of muscle-invasive bladder cancer . Eur Urol . 2020 ; 77 ( 4 ): 420 - 33 .

Tran L , Xiao JF , Agarwal N , Duex JE , Theodorescu D . Advances in bladder cancer biology and therapy . Nat Rev Cancer . 2021 ; 21 ( 2 ): 104 - 21 .

Schafer EJ , Jemal A , Wiese D , Sung H , Kratzer TB , Islami F , et al . Disparities and trends in genitourinary cancer incidence and mortality in the USA . Eur Urol . 2023 ; 84 ( 1 ): 117 - 26 .

Messina E , Proietti F , Laschena L , Flammia RS , Pecoraro M , Cipollari S , et al . MRI for risk stratification of muscle invasion by upper tract urothelial carcinoma: a feasibility study . Eur Radiol Exp . 2024 ; 8 ( 1 ): 9 .

Miyake M , Hirao S , Mibu H , Tanaka M , Takashima K , Shimada K , et al . Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer . BMC Urol . 2011 ; 11 : 17 .

Peng HT , Siddiqui MM , Rhind SG , Zhang J , da Luz LT , Beckett A . Artificial intelligence and machine learning for hemorrhagic trauma care . Mil Med Res . 2023 ; 10 ( 1 ): 6 .

Hamet P , Tremblay J . Artificial intelligence in medicine . Metabolism . 2017 ; 69S : S36 - S40 .

Van Der Velden BHM , Kuijf HJ , Gilhuijs KGA , Viergever MA . Explainable artificial intelligence (XAI) in deep learning-based medical image analysis . Med Image Anal . 2022 ; 79 : 102470 .

Stahlschmidt SR , Ulfenborg B , Synnergren J . Multimodal deep learning for biomedical data fusion: a review . Brief Bioinform . 2022 ; 23 ( 2 ): bbab569 .

Suarez-Ibarrola R , Hein S , Reis G , Gratzke C , Miernik A . Current and future applications of machine and deep learning in urology: a review of the literature on urolithiasis, renal cell carcinoma, and bladder and prostate cancer . World J Urol . 2020 ; 38 ( 10 ): 2329 - 47 .

Li M , Jiang Z , Shen W , Liu H . Deep learning in bladder cancer imaging: a review . Front Oncol . 2022 ; 12 : 930917 .

Arendt CT , Leithner D , Mayerhoefer ME , Gibbs P , Czerny C , Arnoldner C , et al . Radiomics of high-resolution computed tomography for the differentiation between cholesteatoma and middle ear inflammation: effects of post-reconstruction methods in a dual-center study . Eur Radiol . 2021 ; 31 ( 6 ): 4071 - 8 .

Martini K , Baessler B , Bogowicz M , Blüthgen C , Mannil M , Tanadini-Lang S , et al . Applicability of radiomics in interstitial lung disease associated with systemic sclerosis: proof of concept . Eur Radiol . 2021 ; 31 ( 4 ): 1987 - 98 .

Mühlbauer J , Egen L , Kowalewski KF , Grilli M , Walach MT , Westhoff N , et al . Radiomics in renal cell carcinoma-a systematic review and meta-analysis . Cancers (Basel) . 2021 ; 13 ( 6 ): 1348

Tang Y , Li S , Zhu L , Yao L , Li J , Sun X , et al . Improve clinical feature-based bladder cancer survival prediction models through integration with gene expression profiles and machine learning techniques . Heliyon . 2024 ; 10 ( 20 ): e38242 .

Xiong S , Fu Z , Deng Z , Li S , Zhan X , Zheng F , et al . Machine learning-based CT radiomics enhances bladder cancer staging predictions: a comparative study of clinical, radiomics, and combined models . Med Phys . 2024 ; 51 ( 9 ): 5965 - 77 .

She Y , He B , Wang F , Zhong Y , Wang T , Liu Z , et al . Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a multi-centre study . EBioMedicine . 2022 ; 86 : 104364 .

Jiang Y , Zhang Z , Yuan Q , Wang W , Wang H , Li T , et al . Predicting peritoneal recurrence and disease-free survival from CT images in gastric cancer with multitask deep learning: a retrospective study . Lancet Digit Health . 2022 ; 4 ( 5 ): e340 - e50 .

Zhang G , Xu L , Zhao L , Mao L , Li X , Jin Z , et al . CT-based radiomics to predict the pathological grade of bladder cancer . Eur Radiol . 2020 ; 30 ( 12 ): 6749 - 56 .

Kirk SLY , Lucchesi FR , Aredes ND , Gruszauskas N , Catto J , Garcia K , et al . The Cancer Genome Atlas Urothelial Bladder Carcinoma Collection (TCGA-BLCA) (Version 8) . The Cancer Imaging Archive ; 2016 . https://doi.org/10.7937/K9/TCIA.2016.8LNG8XDR https://doi.org/10.7937/K9/TCIA.2016.8LNG8XDR .

Jiang Y , Liang X , Han Z , Wang W , Xi S , Li T , et al . Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study . Lancet Digit Health . 2021 ; 3 ( 6 ): e371 - e82 .

In H , Solsky I , Palis B , Langdon-Embry M , Ajani J , Sano T . Validation of the 8th edition of the AJCC TNM staging system for gastric cancer using the National Cancer Database . Ann Surg Oncol . 2017 ; 24 ( 12 ): 3683 - 91 .

You C , Li G , Zhang Y , Zhang X , Shan H , Li M , et al . CT super-resolution GAN constrained by the identical, residual, and cycle learning ensemble (GAN-CIRCLE) . IEEE Trans Med Imaging . 2020 ; 39 ( 1 ): 188 - 203 .

Guerreiro J , Tomás P , Garcia N , Aidos H . Super-resolution of magnetic resonance images using generative adversarial networks . Comput Med Imaging Graph . 2023 ; 108 : 102280 .

Denlinger CS , Sanft T , Baker KS , Baxi S , Broderick G , Demark-Wahnefried W , et al . Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology . J Natl Compr Canc Netw . 2017 ; 15 ( 9 ): 1140 - 63 .

Ueno Y , Tamada T , Takeuchi M , Sofue K , Takahashi S , Kamishima Y , et al . VI-RADS: multi-institutional multireader diagnostic accuracy and interobserver agreement study . AJR Am J Roentgenol . 2021 ; 216 ( 5 ): 1257 - 66 .

Panebianco V , Narumi Y , Altun E , Bochner BH , Efstathiou JA , Hafeez S , et al . Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System) . Eur Urol . 2018 ; 74 ( 3 ): 294 - 306 .

Bhinder B , Gilvary C , Madhukar NS , Elemento O . Artificial intelligence in cancer research and precision medicine . Cancer Discov . 2021 ; 11 ( 4 ): 900 - 15 .

Bi WL , Hosny A , Schabath MB , Giger ML , Birkbak NJ , Mehrtash A , et al . Artificial intelligence in cancer imaging: clinical challenges and applications . CA Cancer J Clin . 2019 ; 69 ( 2 ): 127 - 57 .

Wu S , Zheng J , Li Y , Yu H , Shi S , Xie W , et al . A radiomics nomogram for the preoperative prediction of lymph node metastasis in bladder cancer . Clin Cancer Res . 2017 ; 23 ( 22 ): 6904 - 11 .

Zhang GM , Sun H , Shi B , Jin ZY , Xue HD . Quantitative CT texture analysis for evaluating histologic grade of urothelial carcinoma . Abdom Radiol (NY) . 2017 ; 42 ( 2 ): 561 - 8 .

Lucas M , Jansen I , Van Leeuwen TG , Oddens JR , De Bruin DM , Marquering HA . Deep learning-based recurrence prediction in patients with non-muscle-invasive bladder cancer . Eur Urol Focus . 2022 ; 8 ( 1 ): 165 - 72 .

Wang H , Zhang M , Miao J , Hou F , Chen Y , Huang Y , et al . Deep learning signature based on multiphase enhanced CT for bladder cancer recurrence prediction: a multi-center study . E Clinical Medicine . 2023 ; 66 : 102352 .

Zhang G , Wu Z , Zhang X , Xu L , Mao L , Li X , et al . CT-based radiomics to predict muscle invasion in bladder cancer . Eur Radiol . 2022 ; 32 ( 5 ): 3260 - 8 .

Garapati SS , Hadjiiski L , Cha KH , Chan HP , Caoili EM , Cohan RH , et al . Urinary bladder cancer staging in CT urography using machine learning . Med Phys . 2017 ; 44 ( 11 ): 5814 - 23 .

Wang H , Xu X , Zhang X , Liu Y , Ouyang L , Du P , et al . Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study . Eur Radiol . 2020 ; 30 ( 9 ): 4816 - 27 .

Borhani S , Borhani R , Kajdacsy-Balla A . Artificial intelligence: a promising frontier in bladder cancer diagnosis and outcome prediction . Crit Rev Oncol Hematol . 2022 ; 171 : 103601 .

Ren Y , Wang G , Wang P , Liu K , Liu Q , Sun H , et al . MM-SFENet: multi-scale multi-task localization and classification of bladder cancer in MRI with spatial feature encoder network . Phys Med Biol . 2024 ; 69 ( 2 ).

Mayerhoefer ME , Materka A , Langs G , Häggström I , Szczypiński P , Gibbs P , et al . Introduction to Radiomics . J Nucl Med . 2020 ; 61 ( 4 ): 488 - 95 .

Haennah JHJ , Christopher CS , King GRG . Prediction of the COVID disease using lung CT images by deep learning algorithm: DETS-optimized Resnet 101 classifier . Front Med (Lausanne) . 2023 ; 10 : 1157000 .

Balagourouchetty L , Pragatheeswaran JK , Pottakkat B , G R . GoogLeNet-Based Ensemble FCNet Classifier for Focal Liver Lesion Diagnosis . IEEE J Biomed Health Inform . 2020 ; 24 ( 6 ): 1686 - 94 .

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Artificial intelligence in orthopedics:fundamentals, current applications, and future perspectives

Pathophysiology-guided biomarkers and therapeutics for precision trauma medicine in polytrauma with musculoskeletal injuries

Integrating artificial intelligence with human reasoning in oncology: questions on real-world implementation and patient-centric evidence

Leveraging artificial intelligence for clinical decision support in personalized standard regimen recommendation for cancer